100 related articles for article (PubMed ID: 18381910)
1. Cannabis, inhibitory neurons, and the progressive course of schizophrenia.
Freedman R
Am J Psychiatry; 2008 Apr; 165(4):416-9. PubMed ID: 18381910
[No Abstract] [Full Text] [Related]
2. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
Schneider M
Addict Biol; 2008 Jun; 13(2):253-63. PubMed ID: 18482434
[TBL] [Abstract][Full Text] [Related]
3. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
Cooper ZD; Haney M
Addict Biol; 2008 Jun; 13(2):188-95. PubMed ID: 18279497
[TBL] [Abstract][Full Text] [Related]
4. Cannabis and psychiatric disorders: it is not only addiction.
Leweke FM; Koethe D
Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
[TBL] [Abstract][Full Text] [Related]
5. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
Coulston CM; Perdices M; Tennant CC
Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
[TBL] [Abstract][Full Text] [Related]
6. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
Di Forti M; Morrison PD; Butt A; Murray RM
Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
[TBL] [Abstract][Full Text] [Related]
7. Toward a prefrontal microcircuit model for cognitive deficits in schizophrenia.
Wang XJ
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S80-7. PubMed ID: 16508903
[TBL] [Abstract][Full Text] [Related]
8. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms].
Jockers-Scherübl MC
Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):533-43. PubMed ID: 17058779
[TBL] [Abstract][Full Text] [Related]
9. [Cannabis and schizophrenia].
Pirkola S
Duodecim; 2003; 119(13):1199-200. PubMed ID: 12908181
[No Abstract] [Full Text] [Related]
10. Cannabis and schizophrenia.
Pushpa-Rajah JA; McLoughlin BC; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
Schizophr Bull; 2015 Mar; 41(2):336-7. PubMed ID: 25552590
[TBL] [Abstract][Full Text] [Related]
11. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
White CM
J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
López-Moreno JA; González-Cuevas G; Moreno G; Navarro M
Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831
[TBL] [Abstract][Full Text] [Related]
13. Interactions between cannabis and schizophrenia in humans and rodents.
Moustafa AA; Salama M; Peak R; Tindle R; Salem A; Keri S; Misiak B; Frydecka D; Mohamed W
Rev Neurosci; 2017 Oct; 28(7):811-823. PubMed ID: 28498796
[TBL] [Abstract][Full Text] [Related]
14. Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens.
Pickel VM; Chan J; Kash TL; Rodríguez JJ; MacKie K
Neuroscience; 2004; 127(1):101-12. PubMed ID: 15219673
[TBL] [Abstract][Full Text] [Related]
15. Advances in the field of cannabinoid--opioid cross-talk.
Robledo P; Berrendero F; Ozaita A; Maldonado R
Addict Biol; 2008 Jun; 13(2):213-24. PubMed ID: 18482431
[TBL] [Abstract][Full Text] [Related]
16. A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro.
Whalley BJ; Wilkinson JD; Williamson EM; Constanti A
Neurosci Lett; 2004 Jul; 365(1):58-63. PubMed ID: 15234473
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids and psychosis.
D'Souza DC
Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
[TBL] [Abstract][Full Text] [Related]
18. Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia.
Lewis DA; Cruz D; Eggan S; Erickson S
Ann N Y Acad Sci; 2004 Jun; 1021():64-76. PubMed ID: 15251876
[TBL] [Abstract][Full Text] [Related]
19. Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia.
Dervaux A; Goldberger C; Gourion D; Bourdel MC; Laqueille X; Lôo H; Olié JP; Krebs MO
Schizophr Res; 2010 Nov; 123(2-3):278-80. PubMed ID: 20832995
[No Abstract] [Full Text] [Related]
20. The endocannabinoid system: emotion, learning and addiction.
Moreira FA; Lutz B
Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
